SEC Form 3 · accession 0001209191-17-064283
Odonate Therapeutics, Inc. · ODT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Odonate Holdings, LLC
10% Owner
Period of report
Dec 6, 2017
Accepted (ET)
Dec 6, 2017 · 8:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001717452
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 3,085,687 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Odonate Holdings, LLC ("Holdings") has granted: (i) Odonate Therapeutics, Inc. ("Odonate") an irrevocable proxy directing Odonate to vote the 2,931,402 shares of Odonate common stock held by Holdings for the benefit of Odonate Management Holdings, LLC, with such vote to be cast in the same proportion as the votes cast by other holders of Odonate common stock; and (ii) Tang Capital Partners, LP ("TCP") an irrevocable proxy granting TCP the authority, at TCP's discretion, to vote the 154,285 shares of Odonate common stock held by Holdings for the benefit of TCP.